methylene blue has been researched along with Viremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eickmann, M; Gravemann, U; Handke, W; Müller, TH; Reichenberg, S; Seltsam, A; Tolksdorf, F | 1 |
| Pereira, A | 1 |
| Pamphilon, D | 1 |
2 review(s) available for methylene blue and Viremia
| Article | Year |
|---|---|
[Viral safety measures of plasma for transfusion and applicability in Spain].
Topics: Blood Coagulation Factors; Blood Donors; Blood Transfusion; Clinical Trials, Phase III as Topic; Consumer Product Safety; Forecasting; Humans; Methylene Blue; Plasma; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Safety; Spain; Transfusion Reaction; Ultraviolet Rays; Viremia; Virus Diseases; Viruses | 2007 |
Viral inactivation of fresh frozen plasma.
Topics: Blood Transfusion; Humans; Methylene Blue; Plasma; PUVA Therapy; Viremia; Viruses | 2000 |
1 other study(ies) available for methylene blue and Viremia
| Article | Year |
|---|---|
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively.
Topics: Animals; Blood Platelets; Chlorocebus aethiops; Coronavirus Infections; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Light; Methylene Blue; Middle East Respiratory Syndrome Coronavirus; Plasma; Ultraviolet Rays; Vero Cells; Viremia; Virus Inactivation | 2018 |